Simplified device re-registration in China from January
This article was originally published in SRA
Starting 1 January, the China Food and Drug Administration will make it easier and quicker for companies to re-register their medical devices if the products have not undergone any significant changes affecting their safety and effectiveness since they were last registered1,2.
You may also be interested in...
Citing challenges posed by the COVID-19 pandemic, EU regulators have extended the deadline for companies to finish nitrosamine-related risk evaluations.
The Australian health care products regulator is inviting feedback on proposed measures to clarify the boundary for software-based products that are captured under the regulatory framework for medical devices.
A draft EU guideline explains how companies can ensure that data from ongoing clinical trials remains relevant for regulatory decision-making despite problems posed by the COVID-19 pandemic.